EPIGENOMICS AG (ECX.DE) Stock Overview
FRA:ECX - DE000A37FT41 - Common Stock
ECX.DE Key Statistics, Chart & Performance
The current stock price of ECX.DE is 0.7 EUR. In the past month the price decreased by -57.32%. In the past year, price increased by 52.84%.
ECX.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 20.11 | 322.93B | ||
| 1ABBV.MI | ABBVIE INC | 19.56 | 314.07B | ||
| AMG.DE | AMGEN INC | 12.86 | 129.66B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 14.76 | 122.10B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.54 | 119.95B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.36 | 87.10B | ||
| ARGX.BR | ARGENX SE | 86.23 | 39.16B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 23.41B | ||
| IDP.DE | BIOGEN INC | 8.63 | 17.39B | ||
| 0QF.DE | MODERNA INC | N/A | 8.21B | ||
| 1MRNA.MI | MODERNA INC | N/A | 7.96B | ||
| 1EXAS.MI | EXACT SCIENCES CORP | N/A | 7.29B |
Related stock screener links
About ECX.DE
Company Profile
Epigenomics AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Berlin, Berlin and currently employs 18 full-time employees. The company went IPO on 2004-07-19. Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.
Company Info
EPIGENOMICS AG
Geneststrasse 5
Berlin BERLIN DE
Employees: 18
Phone: 4930243450
EPIGENOMICS AG / ECX.DE FAQ
What is the stock price of EPIGENOMICS AG today?
The current stock price of ECX.DE is 0.7 EUR. The price decreased by -11.17% in the last trading session.
What is the ticker symbol for EPIGENOMICS AG stock?
The exchange symbol of EPIGENOMICS AG is ECX and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is ECX.DE stock listed?
ECX.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for EPIGENOMICS AG stock?
6 analysts have analysed ECX.DE and the average price target is 16.32 EUR. This implies a price increase of 2231.43% is expected in the next year compared to the current price of 0.7. Check the EPIGENOMICS AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EPIGENOMICS AG worth?
EPIGENOMICS AG (ECX.DE) has a market capitalization of 23.90K EUR. This makes ECX.DE a Nano Cap stock.
How many employees does EPIGENOMICS AG have?
EPIGENOMICS AG (ECX.DE) currently has 18 employees.
What are the support and resistance levels for EPIGENOMICS AG (ECX.DE) stock?
EPIGENOMICS AG (ECX.DE) has a resistance level at 1.72. Check the full technical report for a detailed analysis of ECX.DE support and resistance levels.
Is EPIGENOMICS AG (ECX.DE) expected to grow?
The Revenue of EPIGENOMICS AG (ECX.DE) is expected to grow by 2136.83% in the next year. Check the estimates tab for more information on the ECX.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EPIGENOMICS AG (ECX.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ECX.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ECX.DE, evaluating the profitability, health, valuation and growth aspects
- EPIGENOMICS AG (ECX.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EPIGENOMICS AG (ECX.DE) Sales and EPS estimates to see what analysts future expectations are.
- EPIGENOMICS AG (ECX.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EPIGENOMICS AG (ECX.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- EPIGENOMICS AG (ECX.DE) Stock Chart to make your own analysis
- EPIGENOMICS AG (ECX.DE) Latest news and press-releases to stay up to date.
Does EPIGENOMICS AG (ECX.DE) stock pay dividends?
ECX.DE does not pay a dividend.
When does EPIGENOMICS AG (ECX.DE) report earnings?
EPIGENOMICS AG (ECX.DE) will report earnings on 2024-09-30.
What is the Price/Earnings (PE) ratio of EPIGENOMICS AG (ECX.DE)?
EPIGENOMICS AG (ECX.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-17.68).
ECX.DE Technical Analysis
ECX.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ECX.DE. ECX.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
ECX.DE Financial Highlights
Over the last trailing twelve months ECX.DE reported a non-GAAP Earnings per Share(EPS) of -17.68. The EPS decreased by -7359.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -386.29% | ||
| ROE | -853.33% | ||
| Debt/Equity | 0.06 |
ECX.DE Forecast & Estimates
6 analysts have analysed ECX.DE and the average price target is 16.32 EUR. This implies a price increase of 2231.43% is expected in the next year compared to the current price of 0.7.
For the next year, analysts expect an EPS growth of 47.75% and a revenue growth 2136.83% for ECX.DE